Strides Pharma acquires branded generics from Sandoz
pre-market1 source ↓written by the desknot a recommendation
- in annual sales
- $1 million
Strides Pharma Science Limited's subsidiary, Strides Pharma International AG, has signed agreements with Sandoz AG to acquire a portfolio of branded generics in Sub-Saharan Africa. This includes products in anti-infective, cardiovascular, and dermatology segments, with several generating over $1 million in annual sales. This move positions Strides among the top five pharmaceutical companies in the region.
Not investment advice. For informational purposes only.